Enzymatic Conversion

Enzymatic Conversion refers to the biochemical processes by which cannabis plants transform precursor compounds into secondary metabolites, particularly cannabinoids and terpenes. This family encompasses the genetic and enzymatic machinery that governs how plants synthesize CBGA (cannabigerolic acid) into THCA, CBDA, CBCA, and other cannabinoid pathways. Understanding enzymatic conversion is central to cannabis breeding because the expression and activity of key synthase enzymes—such as THCA synthase and CBDA synthase—determine the chemical profile of a cultivar. Breeders working with enzymatic conversion genetics aim to stabilize or shift cannabinoid ratios and terpene production through selective breeding and genotype identification. This trait family is not directly visible in plant morphology but is revealed through laboratory testing and progeny evaluation.

Breeders leverage enzymatic conversion genetics to develop cultivars with consistent cannabinoid ratios, create high-CBD or balanced THC:CBD lines, and explore rare cannabinoid pathways. Stability of enzymatic output across generations requires understanding the genetic loci controlling synthase expression and cofactor availability.